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Short Report Screening families of patients with premature 
coronary heart disease to identify avoidable 
cardiovascular risk: a cross-sectional study of family 
members and a general population comparison 
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Abstract
Background: Primary prevention should be targeted at individuals with high global cardiovascular risk, but research is 
lacking on how best to identify such individuals in the general population. Family history is a good proxy measure of 
global risk and may provide an efficient mechanism for identifying high risk individuals. The aim was to test the 
feasibility of using patients with premature cardiovascular disease to recruit family members as a means of identifying 
and screening high-risk individuals.
Findings: We recruited family members of 50 patients attending a cardiology clinic for premature coronary heart 
disease (CHD). We compared their cardiovascular risk with a general population control group, and determined their 
perception of their risk and current level of screening. 103 (36%) family members attended screening (27 siblings, 48 
adult offspring and 28 partners). Five (5%) had prevalent CHD. A significantly higher percentage had an ASSIGN risk 
score >20% compared with the general population (13% versus 2%, p < 0.001). Only 37% of family members were 
aware they were at increased risk and only 50% had had their blood pressure and serum cholesterol level checked in 
the previous three years.
Conclusions: Patients attending hospital for premature CHD provide a mechanism to contact family members and this 
can identify individuals with a high global risk who are not currently screened.
Findings
Primary prevention of cardiovascular disease (CVD) is
most effective if people are selected for intervention on
the basis of their overall cardiovascular risk [1]. The Scot-
tish Intercollegiate Guidelines Network (SIGN) recom-
mends treatment of anyone at more than 20% risk of a
cardiovascular event over the subsequent 10 years [1]. In
Scotland, this is determined using the ASSIGN risk score
derived from data on individual risk factors: age, sex,
socioeconomic status, family history of CVD, cigarette
smoking, systolic blood pressure, diabetes, and total and
HDL cholesterol [2]. However, determining which mem-
bers of the general population have a high cardiovascular
risk score is problematic. In England, the Department of
Health has advocated mass screening of the whole popu-
lation [3], but this is a high cost, low yield strategy [4], and
some people are not in regular contact with primary care.
Cardiovascular disease tends to aggregate in families as
a result of both genetic predisposition and clustering of
adverse lifestyles. In Scotland, the 28% of individuals
whose parents die of CVD account for 61% of everyone
with a high global cardiovascular risk [4]. Therefore, tar-
geting screening at those with a family history of CVD
offers a cost effective alternative to mass screening [4].
Guidelines already advocate screening of people with a
family history of CVD [1,5]. General Practitioners are
expected to record family history, along with other risk
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factors, and screen individuals accordingly, but previous
surveys suggest that this strategy has not been effective
[6]. The aim was to test the feasibility of using patients
attending hospital for premature coronary heart disease
to identify and contact family members as a means of tar-
geting screening at high-risk individuals. The objectives
were to determine current levels of awareness and
screening among family members and their uptake of
screening.
We recruited 50 consecutive patients attending the car-
diology outpatient clinic at Monklands Hospital, Scot-
land, for premature CHD. Premature CHD was defined as
chronic stable angina plus angiographic confirmation of
>50% stenosis in a man less than 55 years of age or a
woman less than 65 years of age. Patients provided con-
tact details of their family members, defined as siblings,
offspring over 20 years of age and co-habiting partners.
Patients were excluded from the study if they had no fam-
ily members
Relatives and partners were then contacted directly to
invite them to attend the index patient's hospital for
screening. We used structured, nurse-administered ques-
tionnaires to collect data on demographic information,
lifestyle cardiovascular risk factors and medical history.
Participants were asked whether they considered their
risk of cardiovascular disease to be the same as the gen-
eral population or higher and whether they had had their
blood pressure and cholesterol level checked over the
previous three years. The research nurse recorded
anthropometric measurements and resting blood pres-
sure, and took a fasting blood sample. Written feedback
on cardiovascular risk factors was provided to partici-
pants and their general practitioners. Approval for the
study was granted by the Lanarkshire Medical Research
Ethics Committee.
The Scottish Health Survey was used to identify a gen-
eral population comparison group. Subjects with a family
history of premature cardiovascular disease were
excluded from the comparison group [7]. We used the
Scottish Health Survey to identify and randomly select
comparison individuals matched to family members (2:1)
by age, sex and deprivation quintile. Family members
were compared with the general population group in
terms of both individual risk factors and ASSIGN score.
Continuous variables were compared using paired t and
Wilcoxon signed rank tests for parametric and non-para-
metric data respectively. Categorical data were compared
using McNemar's chi-squared and exact tests, and ordi-
nal data were compared using conditional logistic regres-
sion. Statistical significance was assumed at the 5% level.
All statistical analyses were performed using SPSS v15.0
software.
The 50 index patients had a median age at diagnosis of
53 years (IQR 49-53), with a median 3 year (IQR 1-7)
delay between diagnosis and recruitment to the study. Of
the 290 family members listed by patients, 103 (36%)
attended for screening; a mean of 2 family members per
patient. The 103 family members comprised 27 (26%) sib-
lings, 48 (47%) adult offspring and 28 (27%) partners. Par-
ticipation rates among siblings, offspring and partners
were 16%, 57% and 76% respectively. The most common
reason cited for non-participation was living too far from
the hospital. Family members had a median age of 41
years and 43% were male. Five (5%) already had estab-
lished CHD. Compared to members of the general popu-
lation with no family history, family members were
significantly more likely to smoke, be obese, and have
hypertension and diabetes (Table 1). ASSIGN risk scores
were higher in family members than the general popula-
tion (median 5.39 versus 2.68, p < 0.001) (Figure 1).
Twelve (13%) family members had an estimated probabil-
ity of a major cardiovascular event in the next 10 years of
at least 20% compared with only 4 (2%) people from the
general population (p < 0.001). Ninety seven (94%) family
members provided information on perceived risk and
previous screening. Only 36 (37%) family members per-
ceived their risk of developing CHD in the future to be
higher than the general population. Awareness of
increased risk was higher among offspring (48%) than
siblings (34%), and lowest among partners (19%). Among
family members, only 48 (50%) had had both their blood
pressure and cholesterol checked within the past three
years, and 33 (34%) within the past year.
Our study demonstrated the feasibility of using patients
with premature CHD as a means by which to identify and
contact people with high global risk who are not cur-
rently screened. Consistent with previous studies, our
results demonstrated that the first degree relatives and
partners of patients with premature CHD had an
increased prevalence of individual risk factors and a
higher overall risk of future coronary events. In spite of
existing guidelines recommending screening of people
Figure 1 Distribution of global cardiovascular risk among family 
members and general population controls.
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with a family history, family members demonstrated a
low awareness of their increased risk and a lack of screen-
ing.
Received wisdom suggests that primary prevention
should be targeted at individuals with a high global car-
diovascular risk rather than on the basis of individual risk
factors [1]. Research has focused on developing risk pre-
diction models and identifying clinical and cost effective
intervention strategies, such as lipid-lowering therapies.
By contrast, there has been a paucity of research into how
best to identify which members of the general population
have a high global risk. In the absence of evidence to the
contrary, policy-makers have promoted mass screening
as the preferred strategy [3]. However, such a strategy is
difficult to deliver in practice and the absolute cost is
high. Targeting high risk sub-groups of the population
such as individuals in deprived communities and those
with a family history offers the potential to identify more
than 84% of those at high global risk by screening only
41% of the population [4]. The merits of mass screening
are questionable since a further 59 people would need be
screened to identify an additional high risk individual at a
cost of £1,358 [4].
Published studies have consistently demonstrated that
people with a family history of premature CHD have a
significantly increased risk of developing CHD, due to a
Table 1: Cardiovascular risk factors among family members and general population controls.
Family members
N = 103
General population
N = 206
P value*
N (%) N (%)
Smoking status
Never 40 (39) 118 (57) < 0.001
Ex 20 (19) 42 (20)
current 43 (42) 46 (22)
Body composition
BMI ≥ 25 76 (75) 121 (59) 0.009
WHR >0.8 (F), >0.9 (M) 72 (72) 114 (57) 0.012
Waist >88 cm (F), >102 cm 
(M)
46 (46) 55 (28) 0.001
Hypertension 35 (35) 50 (25) 0.071
Diabetes 9 (9) 0 (0) < 0.001
Cholesterol:HDL ratio >4.0 52 (51) 64 (31) 0.001
Established CHD 5 (5%) 0 (0%) 0.004
Median (IQR) Median (IQR)
Number of cigarettes 
smoked
15 (10, 20) 12 (6, 16) 0.049
Systolic blood pressure 129 (119, 142) 124 (115, 133) 0.005
BMI 28 (25, 32) 26 (24, 28) < 0.001
HDL cholesterol 1.2 (1.0, 1.6) 1.5 (1.2, 1.8) < 0.001
Waist (cm) 94.5 (86.1, 104.0) 87.2 (81.2, 97.0) < 0.001
Mean (SD) Mean (SD)
WHR 0.89 (0.09) 0.86 (0.07) < 0.001
Total cholesterol 5.3 (1.3) 5.4 (1.0) 0.341
N number, BMI body mass index, WHR waist hip ratio, cm centimetres, F female, M male, HDL high density lipoprotein, CHD coronary heart 
disease
*paired t test for WHR and total cholesterol, Wilcoxon paired signed rank test for remainder of continuous variables, Conditional logistic 
regression for smoking status, McNemar's exact test for diabetes and established CHD, McNemar's χ2 test for remainder of categorical 
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combination of shared genetic predisposition and shared
lifestyle [8-10]. Guidelines already exist recommending
screening of people with a family history [1,5], yet less
than half of the family members in our study had had
their blood pressure and cholesterol measured in the past
three years. In the EuroAspire II Survey even fewer
(11.1% of siblings and 5.6% of offspring) had undergone
screening specifically "as a result of CHD in their family"
[6]. This may be due, in part, to lack of awareness that risk
can cluster in families. In previous studies, around half of
people with a parental history of premature CHD were
aware they were at increased risk [11,12]. In our study the
figures were even lower, with only 41% of first degree rel-
atives aware of their increased risk. Partners of patients
with CHD have also been demonstrated to be at
increased risk, as a result of shared lifestyle [13]. Despite
this partners have largely been excluded from research
studies and guidelines [1,5], and, in our study, less than
o n e - f i f t h  o f  p a r t n e r s  w e r e  a w a r e  t h a t  t h e y  w e r e  a t
increased risk.
The strengths of our study included recruitment of
unselected patients and inclusion of partners, as well as
first degree relatives. Previous studies have tended to
compare individual risk factors, whereas our study also
compared global risk. Our comparison group was
matched at an individual level for age, sex and depriva-
tion quintile and was drawn from the same population.
They were not recruited as part of the same study but the
same questions and measurements were administered. A
limitation of this study, as with previous studies, is the
exclusion of fatal index cases of CHD. Compared with
non-fatal cases, family members of fatal cases may have a
different risk profile, risk perception and level of motiva-
tion.
Our patients were recruited a median of three years
after diagnosis, during which time some family members
may have been screened and treated. Therefore, our
results are likely to underestimate the level of increased
risk among family members at the time of diagnosis. The
fact that more than half of family members had not been
screened since diagnosis demonstrates that existing strat-
egies are not effective. We believe that the failure of exist-
ing guidelines has resulted from a reliance on general
practitioners recording family history as a risk factor and
targeting individuals accordingly. An alternative
approach is to ask patients presenting with premature
CHD to provide details of their family members. Com-
pared with screening of the general population, recruit-
ment triggered by a diagnosis of CHD in a family member
could lead to greater motivation to attend screening and
modify lifestyle. This approach is routine practice for a
number of familial cancers. In cardiological practice it is
used for familial dyslipidaemia but, as yet, not for general
cardiovascular screening.
In our study, only 36% of invited family members
attended. We can only speculate as to whether attendees
were representative of all family members and, therefore,
whether the results are generalisable. Recruitment bias
could potentially operate in either direction with partici-
pation being more likely either among those with pre-
existing awareness and concerns, or those hitherto
neglected. In our study, recruitment and screening were
both based in a single hospital. We did not have ethics
committee permission to question non-participants as to
their reason for non-attendance. However, excessive dis-
tance from the clinic was commonly volunteered as a rea-
son for non-attendance. Extension of the screening
service to include multiple sites across the country, would
probably improve uptake.
Our findings suggest that patients presenting with pre-
mature CHD may provide a mechanism to identify family
members and thereby improve cardiovascular screening.
This strategy should be evaluated in a larger, multi-centre
study.
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